SQY Therapeutics
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 2015-01-01
- Employees
- 11
- Market Cap
- -
Phase 1/2a for Safety, PK and PD of SQY51 in Paediatric and Adult Patients Duchenne Muscular Dystrophy
Phase 1
Recruiting
- Conditions
- Duchenne Muscular Dystrophy
- Interventions
- Drug: Phase 1, SQY51Drug: Phase 2a, SQY51 (cohort 3)Drug: Phase 2a, SQY51 (cohort 1)Drug: Phase 2a, SQY51 (cohort 2)
- First Posted Date
- 2023-03-03
- Last Posted Date
- 2024-04-01
- Lead Sponsor
- Sqy Therapeutics
- Target Recruit Count
- 12
- Registration Number
- NCT05753462
- Locations
- 🇫🇷
Hôpital Raymond Poincaré, Garches, France
© Copyright 2025. All Rights Reserved by MedPath